Intestinal stromal cells in mucosal immunity and homeostasis

Mucosal Immunology

Volumn 6, Issue 2, 2013, Pages 224-234

  Owens, B M J ^a   Simmons, A ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 24; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; CYTOKINE RESPONSE; ENTERITIS; EPITHELIUM CELL; GRANULOCYTE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINAL STROMA CELL; INTESTINE EPITHELIUM; INTRACELLULAR SIGNALING; LYMPHOID ORGAN; MOLECULAR DYNAMICS; MUCOSAL HOMEOSTASIS; MUCOSAL IMMUNITY; NON HEMATOPOIETIC IMMUNE CELL; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; SECONDARY LYMPHOID ORGAN; STROMA CELL; T LYMPHOCYTE; TERTIARY LYMPHOID ORGAN;

EID: 84874028273     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.125     Document Type: Review

References (127)

1. Maloy, K.J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011).
2. Cooney, R. et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90-97 (2010).
3. Travassos, L.H. et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62 (2010).
4. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
5. Glocker, E.O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
6. Villani, A.C. et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71-76 (2009).
7. Koning, J.J. &Mebius, R.E. Interdependence of stromal and immune cells for lymph node function. Trends Immunol. 33, 264-270 (2012).
8. Pinchuk, I.V. et al. Intestinal mesenchymal cells. Curr. Gastroenterol. Rep 12, 310-318 (2010).
9. Powell, D.W. et al. Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 73, 213-237 (2011).
10. Mifflin, R.C. et al. Intestinal myofibroblasts: targets for stem cell therapy. American journal of physiology. Gastrointest. Liver Physiol. 300, G684-G696 (2011).
11. Andoh, A. et al. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 114, 94-106 (2007).
12. Reilkoff, R.A., Bucala, R. & Herzog, E.L. Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11, 427-435 (2011).
13. Kolonin, M.G. et al. Alternative origins of stroma in normal organs and disease. Stem Cell Res. 8, 312-323 (2012).
14. Uehara, H. et al. Emergence of fibrocytes showing morphological changes in the inflamed colonic mucosa. Digest. Dis. Sci. 55, 253-260 (2010).
15. Flier, S.N. et al. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J. Biol. Chem. 285, 20202-20212 (2010).
16. Le Blanc, K. & Mougiakakos, D. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 12, 383-396 (2012).
17. Dazzi, F., Lopes, L. &Weng, L.Mesenchymal stromal cells: a key player in 'innate tolerance'?. Immunology 137, 206-213 (2012).
18. Lahar, N. et al. Intestinal subepithelial myofibroblasts support in vitro and in vivo growth of human small intestinal epithelium. PloS One 6, e26898 (2011).
19. Samuel, S. et al. Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts. American journal of physiology. Cell Physiol. 296, C296-C305 (2009).
20. Francoeur, C. et al. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology 136, 268-277.e3 (2009).
21. Farin, H.F., Van Es, J.H. & Clevers, H. Redundant sources of Wnt regulate intestinal stem cells and promote formation of paneth cells. Gastroenterology 143, 1518-1529.e7 (2012).
22. Brown, S.L. et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117, 258-269 (2007).
23. Powell, D.W. & Saada, J.I. Mesenchymal stem cells and prostaglandins may be critical for intestinal wound repair. Gastroenterology 143, 19-22 (2012).
24. Kosinski, C. et al. Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology 139, 893-903 (2010).
25. van Dop, W.A. et al. Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the hedgehog pathway. Gastroenterology 136, 2195-2203.e1-7 (2009).
26. Rieder, F. & Fiocchi, C. Intestinal fibrosis in IBD - a dynamic, multifactorial process. Nat. Rev. Gastroenterol. Hepatol. 6, 228-235 (2009).
27. Rieder, F. et al. Wound healing and fibrosis in intestinal disease. Gut 56, 130-139 (2007).
28. Friedman, S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008).
29. Masamune, A. et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol.Hepatol. 7 (11 Suppl), S48- S54 (2009).
30. Barnes, P.J. Pathophysiology of allergic inflammation. Immunol. Rev. 242, 31-50 (2011).
31. Neumann, E. et al. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol. Med. 16, 458-468 (2010).
32. Buckley, C.D. et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22, 199-204 (2001).
33. McGettrick, H.M. et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur. J. Immunol. 39, 113-125 (2009).
34. Filer, A. et al. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Front. Biosci. 13, 2674-2685 (2008).
35. Piera-Velazquez, S. et al. Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis. Ann. Rheum. Dis. 69, 2017-2023 (2010).
36. Li, M. et al. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J. Immunol. 187, 2711-2722 (2011).
37. Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544-550 (2010).
38. Karouzakis, E. et al. Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 64, 1809-1817 (2012).
39. Russell, S.B. et al. Epigenetically altered wound healing in keloid fibroblasts. J. Investig. Dermatol. 130, 2489-2496 (2010).
40. Ospelt, C. et al. Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?. Autoimmunity Rev. 10, 519-524 (2011).
41. Armaka, M. et al. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205, 331-337 (2008).
42. Roulis, M. et al. Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology. Proc. Natl. Acad. Sci.USA 108, 5396-5401 (2011).
43. Kontoyiannis, D. et al. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196, 1563-1574 (2002).
44. De, L.K.T., Whiting, C.V. & Bland, P.W. Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling. Clin. Exp. Immunol. 147, 313-323 (2007).
45. McKaig, B.C. et al. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am. J. Physiol. Cell Physiol. 282, C172-C182 (2002).
46. Di Sabatino, A. et al. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 133, 137-149 (2007).
47. Lang, M. et al. Gene expression profiles of mucosal fibroblasts from strictured and nonstrictured areas of patients with Crohn's disease. Inflamm. Bowel Dis. 15, 212-223 (2009).
48. McKaig, B.C. et al. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am. J. Pathol. 162, 1355-1360 (2003).
49. Cunningham, M.F. et al. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration. American journal of physiology. Gastrointest. Liver Physiol. 299, G457-G466 (2010).
50. Bajaj-Elliott, M. et al. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts. Am. J. Pathol. 151, 1469-1476 (1997).
51. Van Praet, L. et al. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat. Rev. Rheumatol. 8, 288-295 (2012).
52. Fritsch, C. et al. Cytokines modulate fibroblast phenotype and epithelialstroma interactions in rat intestine. Gastroenterology 112, 826-838 (1997).
53. Andoh, A. et al. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunol. 183, 687-695 (2009).
54. Kruidenier, L. et al. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. Gastroenterology 130, 127-136 (2006).
55. Lippert, E. et al. Soluble galectin-3 is a strong, colonic epithelial-cellderived, lamina propria fibroblast-stimulating factor. Gut 56, 43-51 (2007).
56. Di Mari, J.F. et al. IL-1alpha-induced COX-2 expression in human intestinal myofibroblasts is dependent on a PKCzeta-ROS pathway. Gastroenterology 124, 1855-1865 (2003).
57. Okuno, T. et al. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelialmyofibroblasts. Scand. J. Gastroenterol. 37, 317-324 (2002).
58. Hata, K. et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G1035-G1044 (2002).
59. Yagi, Y. et al. Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J. Gastroenterol. 42, 746-753 (2007).
60. Andoh, A. et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129, 969-984 (2005).
61. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
62. Andoh, A. et al. Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts. Int. J. Mol.Med. 10, 631-634 (2002).
63. Bamba, S. et al. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G529-G538 (2003).
64. Monteleone, G. et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55, 1774-1780 (2006).
65. Stolfi, C. et al. Involvement of interleukin-21 in the regulation of colitisassociated colon cancer. J. Exp. Med. 208, 2279-2290 (2011).
66. Yagi, Y. et al. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int. J. Mol. Med. 19, 941-946 (2007).
67. Sponheim, J. et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 177, 2804-2815 (2010).
68. Kobori, A. et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J. Gastroenterol. 45, 999-1007 (2010).
69. Ina, K. et al. Intestinal fibroblast-derived IL-10 increases survival of mucosal Tcells by inhibiting growth factor deprivation- and Fas-mediated apoptosis. J. Immunol. 175, 2000-2009 (2005).
70. Pinchuk, I.V. et al. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology 140, 2019-2030 (2011).
71. Saada, J.I. et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J. Immunol. 177, 5968-5979 (2006).
72. Saada, J.I. et al. Intestinal myofibroblasts and immune tolerance. Ann. NY Acad. Sci. 1029, 379-381 (2004).
73. Pinchuk, I.V. et al. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterology 135, 1228-1237. 1237 e1-2 (2008).
74. Fletcher, A.L. et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207, 689-697 (2010).
75. Lukacs-Kornek, V. et al. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat. Immunol. 12, 1096-1104 (2011).
76. Siegert, S. et al. Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide. PloS One 6, e27618 (2011).
77. Khan, O. et al. Regulation of Tcell priming by lymphoid stroma. PloS One 6, e261382011).
78. Roberts, A.I., Nadler, S.C. & Ebert, E.C. Mesenchymal cells stimulate human intestinal intraepithelial lymphocytes. Gastroenterology 113, 144-150 (1997).
79. Zhang, Z. et al. Interleukin-1beta and tumor necrosis factor-alpha upregulate interleukin-23 subunit p19 gene expression in human colonic subepithelial myofibroblasts. Int. J. Mol. Med. 15, 79-83 (2005).
80. Bataille, F. et al. Morphological characterisation of Crohn's disease fistulae. Gut 53, 1314-1321 (2004).
81. Fritz, J.H. et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481, 199-203 (2012).
82. Kang, H.S. et al. Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat. Immunol. 3, 576-582 (2002).
83. Fagarasan, S. et al. In situ class switching and differentiation to IgAproducing cells in the gut lamina propria. Nature 413, 639-643 (2001).
84. Pearson, C., Uhlig, H.H. & Powrie, F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol. 33, 289-296 (2012).
85. Norrmen, C. et al. Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity. Blood 115, 906-909 (2010).
86. Neyt, K. et al. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 33, 297-305 (2012).
87. McNamee, E.N. et al. Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis. Gut; doi: 10.1136/gutjnl-2011-301272 (2012).
88. Peduto, L. et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J. Immunol. 182, 5789-5799 (2009).
89. Weninger,W. et al. Naive Tcell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J. Immunol. 170, 4638-4648 (2003).
90. Sato, M. et al. Stromal activation and formation of lymphoid-like stroma in chronic lung allograft dysfunction. Transplantation 91, 1398-1405 (2011).
91. Link, A. et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am. J. Pathol. 178, 1662-1675 (2011).
92. Sellge, G. et al. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by amechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J. Immunol. 172, 260-267 (2004).
93. Montier, Y. et al. Central role of IL-6 and MMP-1 for cross talk between human intestinal mast cells and human intestinal fibroblasts. Immunobiology 217, 912-919 (2012).
94. Xu, X. et al. Mast cells and eosinophils have a potential profibrogenic role in Crohn disease. Scand. J. Gastroenterol. 39, 440-447 (2004).
95. Furuta, G.T. et al. Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin. Exp. Immunol. 122, 35-40 (2000).
96. Wong, C.K. et al. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PloS One 7, e29815 (2012).
97. Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. US A 105, 10913-10918 (2008).
98. Seidelin, J.B., Rogler, G. & Nielsen, O.H. A role for interleukin-33 in T(H)2- polarized intestinal inflammation?. Mucosal Immunol. 4, 496-502 (2011).
99. Rogler, G. et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand. J. Gastroenterol. 36, 389-398 (2001).
100. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (1996).
101. Andoh, A. et al. Interleukin-17 augments tumor necrosis factor-alphainduced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts. J. Gastroenterol. 40, 802-810 (2005).
102. Owens, B.M.J. & Kaye, P.M. Stromal cell induction of regulatory dendritic cells. Front. Immun. 3, 262 (2012).
103. Kaieda, S. et al. Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1). The J. iol. Chem. 285, 21478-21486 (2010).
104. Bimczok, D. et al. Stromal regulation of human gastric dendritic cells restricts the Th1 response to Helicobacter pylori. Gastroenterology 141, 929-938 (2011).
105. Feng, T. et al. Regulation of Toll-like receptor 5 gene expression and function on mucosal dendritic cells. PloS One 7, e35918 (2012).
106. Smythies, L.E. et al. Mucosal IL-8 and TGF-beta recruit bloodmonocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J. Leuk. Biol. 80, 492-499 (2006).
107. Kim, Y.G. et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34, 769-780 (2011).
108. Normand, S. et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad Sci. USA 108, 9601-9606 (2011).
109. Otte, J.M., Rosenberg, I.M. & Podolsky, D.K. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124, 1866-1878 (2003).
110. Zhang, Z. et al. Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts. J. Gastroenterol. Hepatol. 20, 619-627 (2005).
111. Walton, K.L., Holt, L. & Sartor, R.B. Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G601-G611 (2009).
112. Burke, J.P. et al. Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts. The Br. J. Surg. 97, 1126-1134 (2010).
113. Pang, G. et al. GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha. Clin. Exp. Immunol. 96, 437-443 (1994).
114. Pinchuk, I.V. et al. Monocyte chemoattractant protein-1 production by intestinal myofibroblasts in response to staphylococcal enterotoxin a: relevance to staphylococcal enterotoxigenic disease. J. Immunol. 178, 8097-8106 (2007).
115. Horsnell, W.G. et al. Delayed goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion in SMC-specific IL-4Ralphadeficient mice. PLoS Pathogens 3, e1 (2007).
116. Marillier, R.G. et al. IL-4R{alpha}-responsive smooth muscle cells increase intestinal hypercontractility and contribute to resistance during acute Schistosomiasis. American journal of physiology. Gastrointest. Liver Physiol. 298, G943-G951 (2010).
117. Svensson, M. & Kaye, P.M. Stromal-cell regulation of dendritic-cell differentiation and function. Trends Immunol. 27, 580-587 (2006).
118. Asquith, M.J. et al. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology 139, 519-529. 529 e1-2 (2010).
119. Pott, J. & Hornef, M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep. 13, 684-698 (2012).
120. Zheng, B. et al. Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am. J. Pathol. 160, 1609-1617 (2002).
121. Sackett, S.D. et al. Foxl1-Cre BAC transgenic mice: a new tool for gene ablation in the gastrointestinal mesenchyme. Genesis 45, 518-522 (2007).
122. Nikitopoulou, I. et al. Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J. Exp. Med. 209, 925-933 (2012).
123. Shin, S. et al. Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev. 25, 1185-1192 (2011).
124. Onder, L. et al. A novel bacterial artificial chromosome-transgenic podoplanin-cre mouse targets lymphoid organ stromal cells in vivo. Front. Immunol. 2, 50 (2011).
125. Frantz, A.L. et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 5, 501-512 (2012).
126. Malhotra, D. et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 13, 499-510 (2012).
127. Fletcher, A.L. et al. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front. Immunol. 2, 35 (2011).